未登录

T

Thomas R. Arkell

Swinburne University of Technology

H指数:15

被引数:1,200

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Effects of prescribed medical cannabis and alcohol on real-world driving performance (CAN-TRACK): a study protocol for a two-phase trial

规定使用医用大麻和酒精对真实世界驾驶表现的影响（CAN-TRACK）：一项两阶段试验的研究方案

IF2

2026-02-060

PRE

Medical cannabis and driving in Australia: Results from the cannabis as medicine survey 2022–2023 (CAMS-22)

医疗大麻与驾驶：2022–2023年大麻作为药物调查（CAMS-22）结果

transportation research part f: traffic psychology and behaviour

IF0

2026-01-060

OAAI

Medical cannabis use in Australia seven years after legalisation: findings from the online Cannabis as Medicine Survey 2022-2023 (CAMS-22)

HARM REDUCTION JOURNAL

IF4

2024-05-283

OAAI

A Semi-Naturalistic, Open-Label Trial Examining the Effect of Prescribed Medical Cannabis on Neurocognitive Performance

IF7.4

2023-11-093

OAAI

Assessment of Medical Cannabis and Health-Related Quality of Life

JAMA NETWORK OPEN

IF9.7

2023-05-0919

OAAI

Medical Cannabis Use Patterns for Sleep Disorders in Australia: Results of the Cross-Sectional CAMS-20 Survey

NATURE AND SCIENCE OF SLEEP

IF3.4

2023-04-013

OAAI

Cannabis containing equivalent concentrations of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) induces less state anxiety than THC-dominant cannabis

PSYCHOPHARMACOLOGY

IF3.3

2022-10-139

OAAI

Effects of psychotropic drugs on ocular parameters relevant to traffic safety: A systematic review

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

IF7.9

2022-10-014

OAAI

Response to: 'Cannabis use before safety sensitive work: What delay is prudent?'

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

IF7.9

2022-06-011

OAAI

Are blood and oral fluid Δ9-tetrahydrocannabinol (THC) and metabolite concentrations related to impairment? A meta-regression analysis

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

IF7.9

2022-03-0123

OAAI

Acute effects of amphetamine and related psychostimulants on impulsivity: a systematic review of clinical trials

苯丙胺和相关精神兴奋剂对冲动的急性作用: 临床试验的系统评价

ADDICTION BIOLOGY

IF2.6

2022-01-186

PRE

Sex differences in acute cannabis effects revisited: Results from two randomized, controlled trials

ADDICTION BIOLOGY

IF2.6

2021-12-2228

OA

Managing the high: developing legislation and detection methods for cannabis impairment

NATURE REVIEWS NEUROSCIENCE

IF26.7

2021-07-205

OAAI

Determining the magnitude and duration of acute Δ9-tetrahydrocannabinol (Δ9-THC)-induced driving and cognitive impairment: A systematic and meta-analytic review

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

IF7.9

2021-07-01105

OAAI

Driving Impairment Following Vaporization of Cannabis Reply

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

IF55

2021-03-231

PRE

State anxiety induced by THC and CBD does not change after correcting for baseline anxiety levels

EUROPEAN NEUROPSYCHOPHARMACOLOGY

IF6.7

2021-03-010

PREAI

Driving-Related Behaviours, Attitudes and Perceptions among Australian Medical Cannabis Users: Results from the CAMS 18-19 Survey

ACCIDENT ANALYSIS AND PREVENTION

IF6.2

2020-12-0134

OAAI

Effect of Cannabidiol and Δ9-Tetrahydrocannabinol on Driving Performance A Randomized Clinical Trial

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

IF55

2020-12-01103

OA

The effect of daily aerobic cycling exercise on sleep quality during inpatient cannabis withdrawal: A randomised controlled trial

每日有氧运动对住院大麻戒断期间睡眠质量的影响: 一项随机对照试验

JOURNAL OF SLEEP RESEARCH

IF3.9

2020-10-197

PREAI

Medical cannabis use in the Australian community following introduction of legal access: the 2018-2019 Online Cross-Sectional Cannabis as Medicine Survey (CAMS-18)

HARM REDUCTION JOURNAL

IF4

2020-06-0884

OAAI